February 24, 2018

Why Your Pharmacist Can’t Tell You That $20 Prescription Could Cost Only $8

By Robert Pear The New York Times February 24, 2018 WASHINGTON — As consumers face rapidly rising drug costs, states across...
Read More
,
February 16, 2018

Washington is taking aim at drug industry middlemen. But can it break their grip on a captive market?

By Casey Ross StatNews February 16, 2018 As Washington’s interest in drug prices has spiked in recent years, a largely invisible...
Read More
,
Protect Access and Innovation - Advocate
February 6, 2018

The California Life Sciences Sector Powers Innovation.

Support the Cause
Read More
, ,
Protect Access and Innovation - Advocate
January 29, 2018

Don’t let California lawmakers threaten patient access to care and the jobs medical innovation provides

Support the Cause
Read More
September 6, 2017

A cancer patient warns: Don’t sacrifice cures for drug price transparency

Cancer is frightening in the abstract, and even more so when it becomes your reality. Three years ago, I was...
Read More
,
September 5, 2017

The Sacramento Bee: Drug Price Bill Is Bad For Business, Patients

"Californians have legitimate concerns about access to affordable drugs, but SB 17 does not address them. It is a bad...
Read More
September 5, 2017

Help Small and Innovative California Biopharmaceutical Companies

Small and innovative biopharmaceutical companies across California are currently investing in the life-saving treatments of tomorrow, creating well-paying jobs throughout...
Read More
,
August 10, 2017

Op-Ed: Help Ensure Rural Physician Access to Continuing Pharmaceutical Education within their Community

"The California Assembly is considering Senate Bill 790 that would significantly limit both the amount and variations of benefits a...
Read More
June 15, 2017

Assembly Should Consider Real Drivers Of Health Costs

"By focusing on list prices [in SB 17], Sen. Ed Hernandez distorts true costs, failing to ask whether drug discounts...
Read More
,
June 2, 2017

Misleading drug pricing bill is wrong prescription

"The California Assembly is currently considering SB 17 that’s being deceptively sold under the label of drug pricing transparency." -...
Read More
,
May 12, 2017

SacBee: Op-Ed: Misguided pharma ‘transparency’ bill is not the answer to affordable prescription drugs

"SB 17 would mean less innovation, less economic growth and less investment in our world-leading bioscience sector. It’s bad medicine...
Read More
,
May 5, 2017

SB 17 is the Wrong Prescription for Rising Health Costs in California

Senate Bill 17, currently under consideration by the legislature, will not do anything to address the price that California consumers...
Read More
,
1 2 3